Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.
Overall, the sessions were well attended and a lot of questions were asked. Two-thirds of the speakers were from industry and the rest from academia. Of particular note, The academics presented cutting-edge science in the antibody discovery and development area. Business representatives from various therapeutic antibody companies discussed in detail various aspects and challenges of building a viable therapeutic antibody company.
Absalus Inc, 2464 Wyandotte Street, Mountain View, CA 94043, USA. snock@abslus.com
Steffen
S
Nock
D000818:Animals; D000911:Antibodies, Monoclonal; D015195:Drug Design; D004345:Drug Industry; D015507:Drugs, Investigational; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D038622:Internationality; D015143:Philadelphia; D012106:Research / Q000639:trends; D045473:Severe acute respiratory syndrome-related coronavirus / Q000276:immunology*; D013678:Technology, Pharmaceutical
D000911:Antibodies, Monoclonal; D015507:Drugs, Investigational